GlaxoSmithKline plc (ADR) (GSK), Eli Lilly & Co. (LLY): This Week in Biotech
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Posts Tagged ‘NYSE:PFE’
Pfizer Inc. (PFE), Apple Inc. (AAPL) & Billionaire Ken Fisher’s Top Stocks
Charlie Munger offers a valuable nugget of investing advice: "Carefully look at what other great investors have done." Fortunately for us, some of the biggest and brightest investors...
Merck & Co., Inc. (MRK): Big Payout, Little Flexibility
Big pharma isn't the first industry many investors envision when dreaming of the big profits to be made from health care stocks.
AstraZeneca plc (ADR) (AZN): Where Investment Dollars Are Headed
As I noted 10 weeks ago, cancer statistics are both staggering and disappointing.
Microsoft Corporation (MSFT), McDonald’s Corporation (MCD): Last Week’s Big Dow Jones Industrial Average (.DJI) Losers
Even though it was a relatively quiet week in terms of economic data pertaining to the U.S., all of the major indexes posted healthy gains.
MannKind Corporation (MNKD): Should You Buy?
Perennial underdog MannKind Corporation (NASDAQ:MNKD) could be on its countdown to liftoff.
EnerNOC, Inc. (ENOC): What Should Investors Do?
Apparently EnerNOC, Inc. (NASDAQ:ENOC)'s first-quarter results didn't do much for investors. The stock sagged after it reported its financial results several days ago.
United Online, Inc. (UNTD), Pfizer Inc. (PFE): On This Day In Business-Econ History…
The first official recognition of Mother's Day occurred nearly a century ago, when on May 9, 1914, President Woodrow Wilson proclaimed the second Sunday in May would thereafter...
Pfizer Inc. (PFE), Citigroup Inc (C): Legendary Investor Is Bullish, Should You Be?
The oldest living investment professional, Irving Kahn, 107 years old, has managed to increase the market value of his long holdings by more than 17.8% in the past three months...
UnitedHealth Group Inc. (UNH) & Stocks Rising Higher
Stocks are pushing up into record territory again, although today's gains are of the modest type a day after the Dow Jones Industrial Average closed above 15,000 for the first...
Gilead Sciences, Inc. (GILD): The Heart Of The Matter
Gilead Sciences, Inc. (NASDAQ:GILD) has exploded over the last few years as a powerhouse of anti-viral medications. Its myriad treatments for HIV have brought in $2 billion...
Amgen, Inc. (AMGN), Johnson & Johnson (JNJ): Boom Or Ticking Time Bomb?
Reaching the coveted $1 billion mark in annual sales is no small feat for a drug.
Pfizer Inc. (PFE): Risks, Hesitations & Key Opportunities
Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count).
Apple Inc. (AAPL), The Walt Disney Company (DIS): Where’s My Mac N’ Cheese?!
How I miss the NBC show, "30 Rock". Suave exec Jack Donaghy asks head writer Liz Lemon if she watches CNBC. "No, CNBC gives me a headache.
GlaxoSmithKline plc (ADR) (GSK): Why Investors Should Consider It
GlaxoSmithKline plc (ADR) (NYSE:GSK) is a pharmaceutical and healthcare company headquartered in the United Kingdom.
Onyx Pharmaceuticals, Inc. (ONXX), Pfizer Inc. (PFE), And Kidney Cancer’s Top Bets
As I noted nine weeks ago, cancer statistics are both staggering and disappointing.
Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS), Pfizer Inc. (PFE): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
The Coca-Cola Company (KO), General Electric Company (GE): The Dow (.DJI)’s 5 Most Loved Stocks
If last decade was the "lost decade," then this decade is certainly something of a rebirth for the markets, which have more than doubled off their recession lows.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Last Week’s Big Dow (.DJI) Losers
After receiving news of lower-than-expected jobless claims, higher-than-expected job growth, and interest-rate cuts by the European Central Bank to 0.5%, the U.S.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): FDA Approves Powerful New Cholesterol Drug
Merck & Co., Inc. (NYSE:MRK) gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer...
Caterpillar Inc. (CAT)’s Surge Pushes Dow (.DJI) 15K
It took a lot longer than many pundits predicted, but we finally hit that ballyhooed mark: Dow 15,000.
Merck & Co., Inc. (MRK) Down, Could’ve Fallen Worse
The problem was the other drugs didn't make up nearly enough of the Singulair loss.
Eli Lilly & Co. (LLY), GlaxoSmithKline plc (ADR) (GSK), And Why You Don’t Have to Run a Cartel to Make Big Profits in Drugs
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Amgen, Inc. (AMGN): What’s Its Next Catalyst?
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE): Take Two Dividend Stocks and Call Me in the Morning
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Who’s Suing Novartis AG (ADR) (NVS), And Why?
Would you hold a pharmaceutical product presentation in Hooters? That's just one of many alleged instances that the U.S.
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS), GlaxoSmithKline plc (ADR) (GSK) & Big Pharma’s Kickback Conundrum
Big pharma is a controversial industry. Along with tobacco companies, they are some of the most vilified businesses in the world.
Auto News: Tesla Motors Inc (TSLA)’s Subpoena, General Motors Company (GM) & Ford Motor Company (F)
Editor's Note: Related tickers: Tesla Motors Inc (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), Cardiovascular Systems Inc (NASDAQ:CSII), Pfizer...
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
D.R. Horton, Inc. (DHI), Verizon Communications Inc. (VZ), Pfizer Inc. (PFE): Exploding Home Prices Support Stocks
Blue-chip stocks are holding onto record highs this afternoon after new data showed that home prices are growing at the fastest rate in nearly seven years.
A Game-Changer For Pfizer Inc. (PFE)
The wealth-building power of compound interest will never cease to amaze me.
Pfizer Inc. (PFE) Holding Dow Jones Industrial Average (.DJI) Back
The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is unchanged following a worse-than-expected earnings release from Pfizer Inc.
How Will Merck & Co., Inc. (MRK)’s Earnings Fare Tomorrow?
Tomorrow, Merck & Co., Inc. (NYSE:MRK) will release its latest quarterly results.
GlaxoSmithKline plc (GSK), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Buy These Patent-Cliff Proof Stocks
Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic medicines and eventually leads to downfall in their sales.
Pfizer Inc. (PFE): Dow (.DJI) May Open Flat As It Disappoints
LONDON -- Stock index futures at 7 a.m.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY): A New Diabetes Duo Emerges
That's the message from today's announcement that Pfizer Inc. (NYSE:PFE) is out-licensing its diabetes drug candidate ertugliflozin to Merck & Co., Inc. (NYSE:MRK).
Raptor Pharmaceutical Corp. (RPTP), AVEO Pharmaceuticals, Inc. (AVEO) & Two FDA Decisions You Can’t Afford to Miss This Week
Last week we focused on five can't-miss earnings reports.
AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer’s Biggest Current and Upcoming Players
As I noted eight weeks ago, cancer statistics are both staggering and disappointing.
AbbVie Inc (ABBV)’s First Quarter: The Full Story of Humira And The 7 Dwarfs
In its first four months of existence, AbbVie Inc (NYSE:ABBV) rewarded investors with gains of almost 26%. Going into month five, those gains seem likely to increase.
Verizon Communications Inc. (VZ), Pfizer Inc. (PFE), AT&T Inc. (T): What Makes Dow (.DJI) Dividends So Important
Many investors rely on dividends for the income they need from their portfolios.
Pfizer Inc. (PFE), Baxter International (BAX), Quest Diagnostics (DGX) & Collecting Dividends From the Healthcare Sector
Continuing on with the dividend trend that my recent articles have been focusing upon, I’d like to now take a look at some solid healthcare companies.
Merck & Co., Inc. (MRK): How This Can Eventually Lead To Healthy Returns
In the big pharma sector, it can oftentimes be hit or miss when seeking the next big growth stock.
Avanir Pharmaceuticals, Inc. (AVNR), Medivation Inc (MDVN) & This Week In Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Pfizer Inc. (PFE), Wal-Mart Stores, Inc. (WMT): The Danger of Low Dividends
Earnings among S&P 500 companies are at an all-time high.
Johnson & Johnson (JNJ): Buying Isn’t for Growth Investors
If there's one health-care stock every investor knows by name, it's Johnson & Johnson (NYSE:JNJ).
Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Potential Game Changers for America’s No. 1 Killer
Heart disease kills nearly 600,000 Americans every year, making it the nation's No. 1 cause of death, according to the Centers for Disease Control and Prevention.
Ralph Lauren Corp (RL): The SEC Changes Its Course
Depending on how often you meet in glass-walled conference rooms, $125 might seem like a lot for a shirt.
Amgen, Inc. (AMGN): Is It a Buy Now?
When it comes to biotechs, Amgen, Inc. (NASDAQ:AMGN) qualifies for the senior citizen discount.
Eli Lilly & Co. (LLY): Will The Big Bets Pay Off?
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
